Literature DB >> 10695453

Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers.

M Haïssaguerre1, P Jaïs, D C Shah, T Arentz, D Kalusche, A Takahashi, S Garrigue, M Hocini, J T Peng, J Clémenty.   

Abstract

INTRODUCTION: We assessed the mode of reinitiation of atrial fibrillation (AF) after cardioversion and the efficacy of ablating these foci of reinitiation in patients with chronic AF. METHODS AND
RESULTS: Fifteen patients, 7 with structural heart disease, underwent mapping and catheter ablation of drug-resistant AF documented to be persistent for 5 +/- 4 months. In all patients, cardioversion was followed by documentation of P on T atrial ectopy and early recurrence, which allowed mapping of the reinitiating trigger or the source of ectopy. Radiofrequency (RF) ablation was performed at pulmonary vein (PV) ostia using a target temperature of 50 degrees C and a power limit of 30 to 40 W, with the endpoint being interruption of all local muscle conduction. A total of 32 arrhythmogenic PVs and 2 atrial foci (left septum and left appendage) were identified: 1, 2, and 3 or 4 PVs in 5, 3, and 6 patients. RF applications at the ostial perimeter resulted in progressively increasing delay, followed by abolition of PV potentials in 8, but potentials persisted in 6. A single ablation session was performed in 7 patients and 8 underwent two or three sessions because of recurrence of AF; ablation was directed at the same source due to recovery of local PV potential or at a different PV. No PV stenosis was noted either acutely or at repeated follow-up angiograms. Nine patients (60%) were in stable sinus rhythm without antiarrhythmic drugs at follow-up of 11 +/- 8 months. Anticoagulants were interrupted in 7 patients.
CONCLUSION: PVs are the dominant triggers reinitiating chronic AF in this patient population. Elimination of PV potentials by ostial RF applications results in stable sinus rhythm in 60%. A larger group and longer follow-up are needed to investigate further the role of trigger ablation in curative therapy for chronic AF.

Entities:  

Mesh:

Year:  2000        PMID: 10695453     DOI: 10.1111/j.1540-8167.2000.tb00727.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  38 in total

1.  Architecture of the pulmonary veins: relevance to radiofrequency ablation.

Authors:  S Y Ho; J A Cabrera; V H Tran; J Farré; R H Anderson; D Sánchez-Quintana
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

2.  Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping.

Authors:  Rishi Arora; Sander Verheule; Luis Scott; Antonio Navarrete; Vikram Katari; Emily Wilson; Dev Vaz; Jeffrey E Olgin
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

Review 3.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 4.  Computational modeling of the human atrial anatomy and electrophysiology.

Authors:  Olaf Dössel; Martin W Krueger; Frank M Weber; Mathias Wilhelms; Gunnar Seemann
Journal:  Med Biol Eng Comput       Date:  2012-06-21       Impact factor: 2.602

5.  Catheter ablation of permanent atrial fibrillation: medium term results.

Authors:  M J Earley; D J R Abrams; A D Staniforth; S C Sporton; R J Schilling
Journal:  Heart       Date:  2005-08-23       Impact factor: 5.994

Review 6.  Pilsicainide for atrial fibrillation.

Authors:  Koichiro Kumagai; Hideko Nakashima; Hideaki Tojo; Tomoo Yasuda; Hiroo Noguchi; Naomichi Matsumoto; Masahiro Ogawa; Keijiro Saku
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Radiofrequency ablation of atrial fibrillation: effectiveness and safety in 102 consecutive patients.

Authors:  J Pontoppidan; J C Nielsen; S H Poulsen; P T Mortensen; A K Pedersen; H K Jensen; P S Hansen
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 8.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 9.  Ablation of atrial fibrillation.

Authors:  Eduardo B Saad; Nassir F Marrouche; Andrea Natale
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

10.  Percutaneous pulmonary vein cryoablation to treat atrial fibrillation.

Authors:  Tom Wong; Vias Markides; Nicholas S Peters; D Wyn Davies
Journal:  J Interv Card Electrophysiol       Date:  2004-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.